Department of Pharmaceutical Biomaterials, School of Pharmacy, Zanjan University of Medical Sciences, Zanjan, Iran.
Student Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
J Biomed Mater Res A. 2018 Nov;106(11):2817-2826. doi: 10.1002/jbm.a.36468. Epub 2018 Aug 27.
In this project, a core-shell polymersome based on miktoarm star-copolymer:methoxy poly-ethylene glycol-lysine-(poly-caprolactone) was synthesized by a new method as controlled targeted drug delivery systems for codelivery of the chemotherapeutic methotrexate (MTX) and curcumin (CUR). Some properties of these nanocarriers (NCs), such as surface morphology, structure, surface charge, stability, and biocompatibility, were evaluated by proton nuclear magnetic resonance, dynamic scanning colorimetry, Fourier-transform infrared spectroscopy, dynamic light scattering, atomic force microscopy, critical aggregation concentration, hemolysis test, MTT assay, and lethal dose 50 (LD50). The AFM results showed that the uniform spherical morphology of NCs have an average size of about ∼60 nm. The drug loading of NCs was about 14.13 and 10.93% for CUR and MTX, respectively. The NCs revealed pH-sensitivity in drug release. The release of drugs from miktoarm-based NCs in neutral pH was lower than in acidic medium because of faster degradation of polymersome in acidic environment. MTT assay results showed that the drug-loaded NCs did not show significant toxicity due to which cell viability maintain over 82% at 300 μg/mL concentration. Also, synthesized miktoarm showed hemolysis lower than 3%. This result was repeated in LD50, and all mice which treat with 5000 mg/kg were still alive after 24 h. These result confirmed safety of miktoarm star copolymer. Eventually, the goal of this study is the application of water-soluble star copolymers miktoarm with pH dependent release properties for designing a new drug delivery carrier and using CUR for enhancing anticancer properties of MTX. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 106A: 2817-2826, 2018.
在这个项目中,通过一种新的方法合成了一种基于多臂星型共聚物:甲氧基聚乙二醇-赖氨酸-(聚己内酯)的核壳聚合物囊泡,作为化学疗法药物甲氨蝶呤(MTX)和姜黄素(CUR)共递送的靶向控制药物递送系统。通过质子核磁共振、动态扫描比色法、傅里叶变换红外光谱、动态光散射、原子力显微镜、临界聚集浓度、溶血试验、MTT 测定法和半数致死剂量 50(LD50)评估了这些纳米载体(NCs)的一些性质,如表面形态、结构、表面电荷、稳定性和生物相容性。原子力显微镜结果表明,NCs 的均匀球形形态的平均粒径约为 60nm。NCs 的 CUR 和 MTX 的载药量分别约为 14.13%和 10.93%。NCs 显示出药物释放的 pH 敏感性。由于聚合物囊泡在酸性环境中更快降解,因此在中性 pH 下,药物从基于多臂的 NCs 中的释放较低。MTT 测定结果表明,载药 NCs 由于其细胞活力保持在 300μg/mL 浓度下超过 82%,因此没有显示出明显的毒性。此外,合成的多臂聚合物在溶血试验中的溶血率低于 3%。LD50 也重复了这一结果,所有用 5000mg/kg 治疗的小鼠在 24 小时后仍然存活。这些结果证实了多臂星型共聚物的安全性。最终,本研究的目标是应用具有 pH 依赖性释放特性的水溶性星型共聚物多臂来设计新型药物递送载体,并使用 CUR 来增强 MTX 的抗癌特性。© 2018 年 Wiley 期刊,Inc. J Biomed Mater Res Part A: 106A: 2817-2826, 2018。